Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	780.57	631.45	566.77	463.93	276.87
Revenue Growth (YoY)	23.61%	11.41%	22.17%	67.56%	-10.69%
Cost of Revenue	317.31	254.11	240.6	254.45	126.25
Gross Profit	463.26	377.34	326.17	209.49	150.62
Selling, General & Admin	284.8	210.36	159.21	172.19	118.96
Research & Development	-	-	-	3.98	9.45
Other Operating Expenses	-1.18	-2.91	-	-	4.58
Total Operating Expenses	283.62	207.45	159.21	176.17	132.99
Operating Income	179.64	169.9	166.96	33.32	17.63
Interest Income	11.29	13.98	15.62	1.05	0.01
Interest Expense	-82.31	-73.97	-83.34	-63.21	-21.01
Other Non-Operating Income (Expense)	-15.99	-11.33	-23.5	-	-
Total Non-Operating Income (Expense)	-87.02	-71.33	-91.23	-62.17	-21
Pretax Income	92.62	98.57	75.73	-28.85	-3.37
Provision for Income Taxes	29.75	29.38	27.58	-3.85	-74.89
Net Income	62.87	69.19	48.16	-25	71.52
Net Income to Common	62.87	69.19	48.16	-25	71.52
Net Income Growth	-9.13%	43.68%	-	-	167.33%
Shares Outstanding (Basic)	32	32	34	34	35
Shares Outstanding (Diluted)	40	40	42	34	41
Shares Change (YoY)	-1.79%	-3.26%	23.53%	-17.58%	16.77%
EPS (Basic)	1.98	2.14	1.43	-0.74	2.05
EPS (Diluted)	1.73	1.86	1.29	-0.74	1.86
EPS Growth	-6.99%	44.19%	-	-	144.74%
Shares Outstanding	31.71	31.44	31.87	33.85	33.66
Free Cash Flow	327.58	203.33	274.29	122.61	101.61
Free Cash Flow Growth	61.11%	-25.87%	123.71%	20.66%	14.95%
Free Cash Flow Per Share	8.25	5.03	6.56	3.62	2.48
Gross Margin	59.35%	59.76%	57.55%	45.15%	54.40%
Operating Margin	23.01%	26.91%	29.46%	7.18%	6.37%
Profit Margin	8.05%	10.96%	8.50%	-5.39%	25.83%
FCF Margin	41.97%	32.20%	48.40%	26.43%	36.70%
EBITDA	405.71	339.06	316.22	172.26	86.55
EBITDA Margin	51.98%	53.69%	55.79%	37.13%	31.26%
EBIT	179.64	169.9	166.96	33.32	17.63
EBIT Margin	23.01%	26.91%	29.46%	7.18%	6.37%
Effective Tax Rate	32.12%	29.80%	36.41%	13.33%	2219.65%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q